Liping Liu
Papers
1
Total Citations
2
H-Index
1
About
Liping Liu is a clinical researcher whose work centers on hepatobiliary surgery and oncology, with a particular focus on optimizing surgical approaches for hepatocellular carcinoma (HCC). Liu's most notable contribution examines the comparative clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection in patients with early-stage HCC classified under the Barcelona Clinic Liver Cancer (BCLC) staging system. This nationwide cohort study addresses one of the most actively debated questions in hepatic surgery — which minimally invasive or open technique offers the greatest benefit for patients with BCLC stage 0/A disease — and provides real-world, population-level evidence to inform clinical decision-making. By incorporating both clinical outcomes and health economic analyses, Liu's research reflects a sophisticated understanding of the practical constraints facing healthcare systems and surgical teams alike. Although still early in its citation trajectory with 2 citations since its 2025 publication, the study's broad scope and policy-relevant findings position it as a meaningful contribution to the surgical oncology literature. Liu's work ultimately seeks to guide standardization of care for HCC patients and improve value-based outcomes in liver cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1